 NEXGEL Inc NASDAQ:NXGL has announced the appointment of Scott Henry as a new independent director to the companys board effective immediately, he will also serve as a member of the boards Audit Committee. Henry is a managing director and senior research analyst at ROTH Capital Partners with 20 years of sell-side coverage in the pharmaceutical, biotechnology and medical device sectors. 